Clinical Trials Directory

Trials / Completed

CompletedNCT04374513

Community Pharmacists Behaviour During Covid-19

SURVEY of RETAIL PHARMACISTS KNOWLEDGE, ROLE & BEHAVIOR DURING COVID-19 VIRUS OUTBREAK

Status
Completed
Phase
Study type
Observational
Enrollment
318 (actual)
Sponsor
Damanhour University · Academic / Other
Sex
All
Age
Healthy volunteers

Summary

During the COVID-19 pandemic, governments issued movement restrictions and placed areas into quarantine to reduce the spread of the disease.Community pharmacists and their teams are a vital healthcare provider during the outbreak; they remain on the frontline of public health by serving as direct points of access for their patients. The retail pharmacists should provide public community, costumers and patients with right and trusted information about covid-19. They also should have role in awareness spreading regarding personnel safety and hygiene

Detailed description

The survey will enroll as many community pharmacists as possible in the survey portion of the study - The number of participates have no limitations, at least 50 participants. The survey will be enrolled in online google form, face to face interview \& semi-structured telephone interviews if possible. The research procedures: 1. An online survey link will include questions regarding the impact of role and behavior of retail pharmacists during covid-19 outbreak. 2. Face to face and semi-structured interviews if possible: For those pharmacists who state that they would like to participate in an interview, a random sample will be contacted. Inclusion Criteria: 1. Post graduated pharmacist. 2. Community pharmacists. Exclusion Criteria: 1. under graduated students. 2. not pharmacist.

Conditions

Timeline

Start date
2020-04-02
Primary completion
2020-06-01
Completion
2020-07-01
First posted
2020-05-05
Last updated
2021-02-03

Locations

2 sites across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04374513. Inclusion in this directory is not an endorsement.

Community Pharmacists Behaviour During Covid-19 (NCT04374513) · Clinical Trials Directory